Zacks Rating on Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX) has an average broker rating of 1.58, which is interpreted as a Buy, as rated by 18 equity analysts. Nonetheless, 11 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 3 other analysts advise a Buy. Nevertheless, the majority of 4 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 2, which is also a Buy.

Boston Scientific Corporation (BSX) : 18 Wall Street analysts covering Boston Scientific Corporation (BSX) believe that the average level the stock could reach for the short term is $26.08. The maximum price target given is $30 and the minimum target for short term is around $20, hence the standard deviation is calculated at $2.99.


Shares of Boston Scientific Corporation rose by 1.01% in the last five trading days and 1.73% for the last 4 weeks. Boston Scientific Corporation is up 7.01% in the last 3-month period. Year-to-Date the stock performance stands at 30.75%. Boston Scientific Corporation (NYSE:BSX): On Tuesdays trading session , Opening price of the stock was $24.16 with an intraday high of $24.33. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $24.08. However, the stock managed to close at $24.11, a loss of 0.04% for the day. On the previous day, the stock had closed at $24.12. The total traded volume of the day was 4,339,079 shares.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.